Provided by Tiger Fintech (Singapore) Pte. Ltd.

Passage Bio, Inc.

5.76
+0.02000.35%
Volume:592.00
Turnover:3.41K
Market Cap:17.97M
PE:-0.28
High:5.76
Open:5.76
Low:5.76
Close:5.74
Loading ...

Passage Bio Inc. Conducted Annual Stockholders Meeting

Reuters
·
31 May

Chardan Capital Reaffirms Their Buy Rating on Passage Bio (PASG)

TIPRANKS
·
15 May

Wedbush Remains a Buy on Passage Bio (PASG)

TIPRANKS
·
13 May

Wedbush Adjusts Price Target on Passage Bio to $3 From $4, Maintains Outperform Rating

MT Newswires Live
·
13 May

Passage Bio Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
13 May

BRIEF-Passage Bio Q1 Income From Operations USD -16.459 Million

Reuters
·
13 May

Passage Bio Q1 EPS $(0.25) Misses $(0.23) Estimate

Benzinga
·
13 May

Passage Bio Inc. Reports Q1 2025 Results: Net Loss Narrows to $15.4M, EPS Improves to $0.25

Reuters
·
13 May

Passage Bio Inc expected to post a loss of 23 cents a share - Earnings Preview

Reuters
·
09 May

Major Stakeholder Makes a Big Move with Passage Bio Shares!

TIPRANKS
·
25 Apr

Major Shareholder Orbimed Advisors Makes a Bold Move with Passage Bio Stock!

TIPRANKS
·
18 Apr

Passage Bio (PASG) Upgraded to Buy: Here's What You Should Know

Zacks
·
08 Mar

Analysts Offer Insights on Healthcare Companies: Ventyx Biosciences (VTYX), Black Diamond Therapeutics (BDTX) and Passage Bio (PASG)

TIPRANKS
·
07 Mar

Chardan Cuts Price Target on Passage Bio to $6 From $7, Keeps Buy Rating

MT Newswires Live
·
05 Mar

U.S. RESEARCH ROUNDUP-Accolade, CrowdStrike, Marriott International

Reuters
·
05 Mar

Passage Bio Is Maintained at Buy by Chardan Capital

Dow Jones
·
05 Mar

Passage Bio Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
05 Mar

Passage Bio Reports 2024 Financial Results and Program Advances

TIPRANKS
·
04 Mar

BRIEF-Passage Bio Reports Fourth Quarter and Full Year 2024 Results

Reuters
·
04 Mar

Passage Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Recent Business Highlights

GlobeNewswire
·
04 Mar